News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Parascript Announces AccuDetect 2.0 Computer Aided Detection Algorithms for Greater Accuracy in Assessing Mammograms


11/17/2008 8:17:56 AM

BOULDER, Colo., Nov. 17 /PRNewswire/ -- Parascript, LLC, the image analysis and pattern recognition technology provider, today announced the release of AccuDetect 2.0, the next generation of its computer-aided detection (CAD) algorithms for mammography. Parascript AccuDetect 2.0 is even more robust with improved performance and increased potential for lowering false-positive rates in detecting suspicious lesions on mammograms. Available for OEM customers interested in reducing false-positive rates of existing CAD systems, AccuDetect is intended to assist radiologists in the early detection of breast cancer during film-based or digital mammography exams.

CAD systems are typically relied upon to identify and highlight hard-to-find features and anomalies on medical images that may be indicative of cancer and bring them to the attention of radiologists. AccuDetect is an enabling technology that easily integrates with existing analog and digital CAD systems to improve the accuracy of data interpretation. Its primary objective is to enable existing CAD systems to reduce false-positive readings through the utilization of voting methodology in medical imaging.

Parascript AccuDetect 2.0 integrates several proprietary algorithms and sophisticated voting methods to achieve low false-positive rates while maintaining high sensitivity rates. The entire process of applying voting methodology during image processing and analysis is best described as the work of a group of highly skilled experts. Each member has unique skills, expertise, and favored approaches. When they work together as a team, the areas of expertise complement each other, resulting in improved overall performance. Comparing the results of multiple image-recognition processes enables the inherent faults of the procedure to be mitigated, resulting in reduced false-positive and false-negative rates.

"Our goal at Parascript is to help our partners create next generation CAD systems with false-positive rates approaching those of a second radiologist. The reduced false-positive rates can ultimately lead to a decrease in medical costs, emotional stress, follow-up examinations, and recalls for healthy patients that were suspected of having a cancer," said Yuri Prizemin, director of product marketing for Parascript.

About Parascript, LLC

The Parascript image analysis suite extracts meaningful information from images. Employing patented digital image analysis and pattern recognition technologies, the Parascript image analysis suite improves decision quality in medical imaging, postal and payment automation, fraud detection and forms processing operations. Parascript software processes over 100 billion imaged documents per year. Fortune 500 companies, postal operators, major government and financial institutions rely on Parascript products. Organizations include the U.S. Postal Service, Bowe Bell + Howell, CheckFree -- now part of Fiserv, Elsag, Lockheed Martin, NCR, Siemens and Unisys. Parascript is online at http://www.parascript.com.

CONTACT: Claudette Allingham of Parascript, LLC, +1-303-381-3100,
claudette.allingham@parascript.com; or Hilary McCarthy of SZPR,
+1-508-829-2543, hilary@szpr.com, for Parascript, LLC

Web site: http://www.parascript.com/


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES